Home›Trial›NCT06345157
🔬NCT06345157ACTIVE NOT RECRUITING

ITAKOS - Italian Observation, Multicenter, Prospective Study of Ofatumumab in RRMS Patients

Study Summary

Study to evaluate the effectiveness of ofatumumab in Italian RRMS patients in the real-life setting.

Conditions
Multiple Sclerosis, Relapsing-Remitting
Interventions / Drugs
Ofatumumab
View on ClinicalTrials.gov ↗
Sponsor
NVS
Novartis AG
Diversified Pharma
D36/100
Study Details
Enrollment379 participants
Primary Completion—
Lead SponsorNovartis Pharmaceuticals
Data Retrieved2026-04-11 02:55:49.152621+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.